Welcome to Investing in Cures 2021
Speakers:
- David Brint – Board Chairman, Foundation Fighting Blindness
- Warren Thaler – Board Chairman, RD Fund
Patient Journeys:
Stories of Hope and Courage
Speakers:
- Evan Mittman Means Business
Board Director, Foundation Fighting Blindness - RP Warriors
Michelle Glaze – Associate Director, Professional Outreach, Foundation Fighting Blindness
John Corneille, JD – Director, Legacy Giving, Foundation Fighting Blindness - Low Vision, High Ambition
Denny Moyer, BS, COTA/L – Founding Member and CEO, Ensight Skills for Low Vision Rehabilitation
Moderators:
- Jason Menzo – COO, Foundation Fighting Blindness
- Ben Shaberman – Senior Director, Scientific Outreach, Foundation Fighting Blindness
Using Adeno-Associated Virus as a Tool to Study Retinal Barriers in Disease
Lab Experiences and Q&A
Get a quick, in-depth overview of commonly used and talked about research experiments through engaging and easy-to understand visual demonstrations. Then spend time with a research scientist who will answer questions on any technical aspect of the lab experience or further your understanding on how it applies to retinal diseases.
Speaker: Deniz Dalkara, PhD – INSERM Researcher, Paris Vision Institute
Moderator: Chad Jackson, PhD – Director, Preclinical Translational Research Program, Foundation Fighting Blindness
A Virtual-Reality System to Measure Visual Acuity and Contrast Sensitivity in Laboratory Rodents
Lab Experiences and Q&A
Get a quick, in-depth overview of commonly used and talked about research experiments through engaging and easy-to understand visual demonstrations. Then spend time with a research scientist who will answer questions on any technical aspect of the lab experience or further your understanding on how it applies to retinal diseases.
Speaker: Glen Prusky, PhD – Professor, Department of Physiology and Biophysics, Weill Cornell Medicine
Moderator: Chad Jackson, PhD
Developing Cell Therapies for Blinding Eye Diseases: From Bench-to-Bedside
Lab Experiences and Q&A
Get a quick, in-depth overview of commonly used and talked about research experiments through engaging and easy-to understand visual demonstrations. Then spend time with a research scientist who will answer questions on any technical aspect of the lab experience or further your understanding on how it applies to retinal diseases.
Speaker: Kapil Bharti, PhD – Senior Investigator, NEI, NIH
Moderator: Chad Jackson, PhD
Improving IRD Diagnostics: Lab Tour at Blueprint Genetics
Lab Experiences and Q&A
Get a quick, in-depth overview of commonly used and talked about research experiments through engaging and easy-to understand visual demonstrations. Then spend time with a research scientist who will answer questions on any technical aspect of the lab experience or further your understanding on how it applies to retinal diseases.
Speaker: Tero-Pekka Alastalo, MD, PhD – Executive Medical Director and Co-Founder, Blueprint Genetics
Moderator: Todd Durham, PhD
The Art of Translation: Moving Beyond the Bench
This panel will showcase the experiences and lessons learned from researchers who have succeeded in moving their preclinical translational projects toward clinical studies.
Speakers:
- Ilyas Washington, PhD – Co-Founder, Alkeus Pharmaceuticals
- Christelle Monville, PhD – Professor, Evry’s University, Team Leader, Istem lab (France)
- Rob Collin, PhD – Professor, Molecular Therapies for IRDs, Radboud University Medical Center
- Mark Vézina, BSc – Director, Ocular and Neuroscience Department, Charles River
Moderators:
- Amy Laster, PhD – VP, Science & Awards Program, Foundation Fighting Blindness
- Chad Jackson, PhD – Director, Preclinical Translational Research Program, Foundation Fighting Blindness
The Executive Roundtable
Leading pharma executive panel will delve into the strategic process for advancing promising treatments through the development pipeline.
Speakers:
- Patrick Ritschel, BS, MBA – CEO, Atsena Therapeutics
- Stéphane Boissel – CEO, SparingVision
- Walter Strapps, PhD – Chief Scientific Officer, Gemini Therapeutics
- Glenn Sblendorio, MBA – CEO and President, Iveric Bio
Moderators:
- Jason Menzo – COO, Foundation Fighting Blindness
- Rusty Kelley, PhD – SVP, Investments & Alliances, Foundation Fighting Blindness
The Ecosystem
A panel of representatives from all sectors of the ocular research and development pipeline will discuss leveraging current successes and momentum in biotechnology to advance treatments for retinal degenerations
Speakers:
- Wiley Chambers, MD – Director, Division of Ophthalmology, Office of Specialty Medicine, Office of New Drugs, Food and Drug Administration
- Stéphane Boissel – CEO, SparingVision
- Richard Awdeh, MD – CEO and Founder, CheckedUp
- Laura Manfre – Co-Founder, Sofia Sees Hope
- Kevin Bitterman, PhD – Partner, Atlas Venture
- Tarran Pierfelice, PhD, MBA – Business Head of National Gene Therapy Franchise, Resilience
- Steve Pakola, MD – Chief Medical Officer, REGENXBIO
Moderators:
- Ben Yerxa, PhD – CEO, Foundation Fighting Blindness
- Eugene de Juan, Jr., PhD – Board Director, RD Fund
Investing in Cures Summit Closing Remarks
Speaker: Adrienne L. Graves, PhD – Board Director, Foundation Fighting Blindness and RD Fund
